Tissue Expanders and Proton Beam Radiotherapy

Tissue Expanders and Proton Beam Radiotherapy: What You Need to Know

Proton beam radiotherapy (PBR) has gained acceptance for the treatment of breast cancer because of unique beam characteristics that allow superior dose distributions with optimal dose to the target and limited collateral damage to adjacent normal tissue, especially to the heart and lungs. To determine the compatibility of breast tissue expanders (TEs) with PBR, we evaluated the structural and d...

Clinical Policy Bulletin: Proton Beam and Neutron Beam Radiotherapy

Proton beam radiotherapy of iris melanoma.

PURPOSE To report on outcomes after proton beam radiotherapy of iris melanoma. METHODS AND MATERIALS Between 1993 and 2004, 88 patients with iris melanoma received proton beam radiotherapy, with 53.1 Gy in 4 fractions. RESULTS The patients had a mean age of 52 years and a median follow-up of 2.7 years. The tumors had a median diameter of 4.3 mm, involving more than 2 clock hours of iris in ...

Proton-beam radiotherapy for early-stage lung cancer.

STUDY OBJECTIVE A prospective study was undertaken to assess the efficacy and toxicity of conformal proton-beam radiotherapy for early-stage, medically inoperable non-small cell lung cancer. DESIGN Eligible patients had clinical stage I to IIIa non-small cell lung cancer and were not candidates for surgical resection for medical reasons or because of patient refusal. Patients with adequate ca...

Proton Beam Radiotherapy - The State of the Art